Fulvestrant (faslodex) in women with advanced breast cancer after progression on prior anti-estrogenic therapy:: Our experience

被引：0
|
作者：
Fusco, O.
Malugani, F.
Menatti, E.
Berardi, E.
Fiumano, M.
Visini, M.
Ciotti, R.
Ardizzoia, A.
Colombo, I
Villa, F.
Giordano, M.
Isa, L.
Comande, M.
Bertolini, A.
机构：
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：XI14 / XI14
页数：1
相关论文
共 50 条
  • [1] Fulvestrant (Faslodex) in women with metastatic breast cancer after progression on prior anti-estrogenic therapy
    Di Bitonto, Pasqualina
    Abate, Antonio
    Vessia, Giacomo
    De Lena, Mario
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : 49 - 49
  • [2] QUALITY OF LIFE RESPONSE IN WOMEN WITH ADVANCED BREAST CANCER RECEIVING FASLODEX (FULVESTRANT) AFTER PROGRESSION ON PRIOR ANTIESTROGEN THERAPY
    Novik, A. A.
    Ionova, T. I.
    Kalyadina, S. A.
    Kishtovich, A. V.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 75 - 75
  • [3] Case studies of fulvestrant ('Faslodex') in postmenopausal women with advanced breast cancer
    Abram, P
    Maass, N
    Rea, D
    Simon, SD
    Steger, GG
    [J]. CANCER TREATMENT REVIEWS, 2005, 31 : S17 - S25
  • [4] Fulvestrant (Faslodex™) in advanced breast cancer:: clinical experience from a Belgian cooperative study
    Neven, Patrick
    Paridaens, Robert
    Pelgrims, Gino
    Martens, Marc
    Bols, Alain
    Goeminne, Jean Charles
    Vindevoghel, Anita
    Demol, Jan
    Stragier, Barbara
    De Greve, Jacques
    Fontaine, Christel
    Van Den Weyngaert, Danielle
    Becquart, Dominique
    Borms, Marleen
    Cocquyt, Veronique
    Van den Broecke, Rudy
    Selleslags, Jean
    Awada, Ahmad
    Dirix, Luc
    Van Dam, Peter
    Azerad, Marie Agnes
    Vandenhoven, Guy
    Christiaens, Marie Rose
    Vergote, Ignace
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2008, 109 (01) : 59 - 65
  • [5] Preclinical and clinical experience with fulvestrant (Faslodex) in postmenopausal women with hormone receptor-positive advanced breast cancer
    Bundred, N
    [J]. CANCER INVESTIGATION, 2005, 23 (02) : 173 - 181
  • [6] Fulvestrant (Faslodex™) in advanced breast cancer: clinical experience from a Belgian cooperative study
    Patrick Neven
    Robert Paridaens
    Gino Pelgrims
    Marc Martens
    Alain Bols
    Jean Charles Goeminne
    Anita Vindevoghel
    Jan Demol
    Barbara Stragier
    Jacques De Greve
    Christel Fontaine
    Danielle Van Den Weyngaert
    Dominique Becquart
    Marleen Borms
    Veronique Cocquyt
    Rudy Van Den Broecke
    Jean Selleslags
    Ahmad Awada
    Luc Dirix
    Peter Van Dam
    Marie Agnes Azerad
    Guy Vandenhoven
    Marie Rose Christiaens
    Ignace Vergote
    [J]. Breast Cancer Research and Treatment, 2008, 109 : 59 - 65
  • [7] CLINICAL BENEFIT OF FULVESTRANT IN POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST CANCER ACCORDING TO PRIOR THERAPY
    De Angelis, Carmine
    Cerillo, Ivana
    Ruocco, Raffaella
    Stanzione, Brigida
    Milano, Monica
    Gargiulo, Piera
    Lauria, Rossella
    Bruzzese, Dario
    Arpino, Grazia
    De Placido, Sabino
    [J]. BREAST, 2013, 22 : S44 - S44
  • [8] Quality of life and symptom treatment response in postmenopausal women with advanced breast cancer (ABC) receiving Fulvestrant after progression on prior antiestrogen therapy
    Kalyadina, S.
    Novik, A.
    Ionova, T.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 195 - 195
  • [9] Combination of anti-estrogenic therapy with radiation in breast cancer: Simultaneous or sequential treatment?
    Schmidberger, H
    Hermann, RM
    Hess, CF
    Emons, G
    [J]. ONKOLOGIE, 2005, 28 (05): : 275 - 280
  • [10] Fulvestrant (Faslodex®) is effective in postmenopausal women with visceral metastases (VM) In advanced breast cancer (ABC)
    Mauriac, L
    [J]. EUROPEAN JOURNAL OF CANCER, 2002, 38 : S96 - S96
12345